AKT1 and glioblastoma: Immunoblotting analysis of 020913 cells when treated with different RTK inhibitors in vitro suggests that to achieve complete growth inhibition of GBM oncosphere lines all of the three pathways involving AKT, STAT3 and MAPK that are downstream of RTKs should be inhibited.